Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Single level serratus anterior plane block | Active Comparator | the allocated patients will receive single injection serratus anterior plane block at the level of third rib with local anesthetics only |
|
| Single level serratus anterior plane block with dexmedetomidine | Experimental | the allocated patients will receive single injection serratus anterior plane block at the level of third rib with local anesthetics and dexmedetomidine |
|
| Bilevel serratus anterior plane block | Experimental | the allocated patients will receive injection serratus anterior plane block at 2 levels, the level of third rib and the level of the fifth rib with local anesthetics only |
|
| Bilevel serratus anterior plane block with dexmedetomidine | Experimental | the allocated patients will receive injection serratus anterior plane block at 2 levels, the level of third rib and the level of the fifth rib with local anesthetics and dexmedetomidine |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Single level serratus anterior plane block | Procedure | Serratus anterior plane block with local anesthetics at the third rib |
|
| Measure | Description | Time Frame |
|---|---|---|
| First time to receive analgesia | first time to receive morphine analgesia in hours | First 24 hours postoperatively |
| Total analgesic requisite | total amount of morphine consumption in the first 24 hours postoperatively in mg | First 24 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Pain scores | pain scores will be assessed using Visual Analogue Scale on a sale from 0 to 10 with 0 meanung no pain and 10 meaning severe pain | First 24 hours postoperatively |
| Side effects | nausea and vomiting and hematoma at site of injection |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Females
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Walaa Y Elsabeeny, MD | Contact | 201007798466 | +2 | walaa.elsabeeny@nci.cu.edu.eg |
| Nahla N Shehab, MD | Contact | 01221682808 | +2 | nahla.shehab2@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Walaa Y Elsabeeny, MD | Assistant Professor of Anesthesia and Pain management | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Walaa Y Elsabeeny | Recruiting | Cairo | Cairo Governorate | 11796 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Single level serratus anterior plane block with dexmedetomidine | Procedure | Serratus anterior plane block with local anesthetics and dexmedetomidine at the third rib |
|
| Bilevel serratus anterior plane block | Procedure | Serratus anterior plane block with local anesthetics at the third and fifth rib |
|
| Bilevel serratus anterior plane block with dexmedetomidine | Procedure | Serratus anterior plane block with local anesthetics and dexmedetomidine at the third and fifth rib |
|
| First 24 hours postoperatively |
| Perioperative heart rate values | heart rate values in the form of beat per minute in the perioperative period including preoperative, intraoperative and postoperative | First 24 hours |
| Mean arterial blood pressure | Mean arterial blood pressure values in the form mmHg in the perioperative period including preoperative, intraoperative and postoperative | First 24 hours |
| ID | Term |
|---|---|
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D020927 | Dexmedetomidine |
| ID | Term |
|---|---|
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided